Disability in systemic sclerosis - A longitudinal observational study

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 685-692

  Schnitzer, Mireille ^a   Hudson, Marie ^a   Baron, Murray ^a   Pope, J E ^b   Markland, J ^b   Masetto, D A ^b   Sutton, E ^b   Khalidi, N A ^b   Robinson, D ^b   Jones, N ^b   Kaminska, E ^b   Docherty, P ^b   Smith, C D ^b   Mathieu, J P ^b   Ligier, S ^b   Mittoo, S ^b   Steele, Russell ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

Disability; Health assessment questionnaire; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; BREATHING DISORDER; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; CANADA; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; QUESTIONNAIRES; REGISTRIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 79953315766     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100635     Document Type: Article

References (33)

1. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis) - classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
2. Siebold J. Scleroderma. In: Harris E, Budd R, Firestein G, Genovese M, Sergent J, Ruddy S, et al, editors. Kelley's textbook of rheumatology. 7th ed. Amsterdam: Elsevier; 2005.
3. Wigley F, Hummers L. Clinical features of systemic sclerosis. In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M, editors. Rheumatology. 3rd ed. Amsterdam: Elsevier; 2006.
4. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78. (Pubitemid 36077790)
5. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
6. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
7. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91. (Pubitemid 27494658)
8. Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-40. (Pubitemid 40676492)
9. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res 1995;8:189-93.
10. Sokka T, Kautiainen H, Hannonen P, Pincus T. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum 2006;54:3113-8. (Pubitemid 44622080)
11. Husted JA, Tom BD, Farewell VT, Schentag CT, Gladman DD. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time? Arthritis Rheum 2007;56:840-9.
12. Ward MM. Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 2002;29:1420-5. (Pubitemid 34755608)
13. Wiles N, Dunn G, Barrett E, Silman A, Symmons D. Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. J Clin Epidemiol 2000;53:988-96.
14. Chakravarty EF, Hubert HB, Lingala VB, Fries JF. Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med 2008;168:1638-46.
15. Shen S, Beunckens C, Mallinckrodt C, Molenberghs G. A local influence sensitivity analysis for incomplete longitudinal depression data. J Biopharm Stat 2006;16:365-84.
16. Schafer JL. Analysis of incomplete multivariate data. London: CRC Press; 1997.
17. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.
18. Boscardin WJ, Yan X, Wong WK. A reanalysis of a longitudinal scleroderma clinical trial using non-ignorable missingness models. J Stat Plan Inference 2007;137:3848-58.
19. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000;43:2751-61. (Pubitemid 32001741)
20. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
21. Khanna D. Health-related quality of life: a primer with a focus on scleroderma. Sclero Care Res 2006;3:3-13.
22. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
23. Jaeschke R, Singer J, Guyatt G. Health-status measurement - ascertaining the minimal clinically important difference. Clin Res 1989;37:A315.
24. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000;18:419-23.
25. Khanna D, Furst DE, Hays RD, Park GS, Wong WK, Seibold JR, et al. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 2006;65:1325-9. (Pubitemid 44620441)
26. Sekhon S, Pope J, Baron M. The minimally important difference in clinical practice for patient-centered outcomes including Health Assessment Questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma. J Rheumatol 2010;37:591-8.
27. Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, et al. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis Rheum 2008;59:867-75. (Pubitemid 351847571)
28. Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, et al. Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol 2007;34:1194-200. (Pubitemid 46774874)
29. Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, et al. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 2008;67:703-9. (Pubitemid 351571937)
30. Schafer JL. Imputation of missing covariates under a multivariate linear mixed model. University Park, PA: Department of Statistics, Pennsylvania State University; 1997. [Internet. Accessed Nov 10, 2010.] Available from: http://www.stat.psu.edu/reports/1997/tr9704.pdf
31. Gonzalez-Alvaro I, Descalzo MA, Carmona L. Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort. Arthritis Res Ther 2008;10:R138.
32. Carpenter JR, Kenward MG, Vansteelandt S. A comparison of multiple imputation and doubly robust estimation for analyses with missing data. J Roy Statist Soc: Series A (Statistics in Society) 2006;169:571-84. (Pubitemid 43877183)
33. Kang JDY, Schafer JL. Demystifying double robustness: A comparison of alternative strategies for estimating a population mean from incomplete data. Stat Sci 2007;22:523-39.